Reprogamming Skin Cells to Act Like Stem Cells
https://reachmd.com/programs/clinicians-roundtable/reprogamming-skin-cells-to-act-like-stem-cells/2588/
Dr. Johnathan Moreno speaks with host Dr. Maurie Pickard about this year’s ground breaking research in the reprogramming of skin cells to act like stem cells. They also discuss the need for new embryonic cell lines that continue to be the gold standard. Continued progress in this area of research, h
Biology of Embryonic Stem Cells
https://reachmd.com/programs/clinicians-roundtable/biology-of-embryonic-stem-cells/2251/
John A. Kessler MD, Davee Professor of Stem Cell Biology, Chairman, Davee Department of Neurology, Northwestern University Medical School in Chicago. Dr. Kessler is one of the world’s leaders in stem cell research to repair central and peripheral nerve damage. He joins us to talk about the biology
Rebuilding Hearts with Stem Cells
https://reachmd.com/programs/innovations-in-medicine/rebuilding-hearts-with-stem-cells/2371/
We’ve heard a lot of talk about using stem cells to produce replacement organs. Many have dismissed it as science fiction. But that's no longer true. Researchers at the University of Minnesota have been quietly perfecting techniques to do precisely that. And they are using not embryonic stem cells—b
The Stem Cell Research Debate
https://reachmd.com/programs/clinicians-roundtable/the-stem-cell-research-debate/967/
Dr. James Sherley, a stem cell heretic, discusses his stem cell views and proposes that many other researchers in his field share his strong views but do not always speak out because of their desire to get tenure and or be published. He also explains his side of the story regarding his tenure at MI
Beyond the Embryonic Stem Cell Debate
https://reachmd.com/programs/clinicians-roundtable/beyond-the-embryonic-stem-cell-debate/4314/
Although President Obama has favored funding for embryonic stem cell research, the moral debate continues. But that discussion may overshadow the fact that biotech companies have actually made the most early progress, not in embryonic stem cells, but in adult stem cells. Dr. Robert Harman, chief exe
https://reachmd.com/programs/clinicians-roundtable/stem-cell-basics/964/
In this segment Dr. James Sherley offers physicians a review course on adult and embryonic stem cells.
Old Human Cells Rejuvenated with Stem Cell Technology
https://reachmd.com/news/old-human-cells-rejuvenated-with-stem-cell-technology/1634083/
med.stanford.edu Old human cells return to a more youthful and vigorous state after being induced to briefly express a panel of proteins involved in embryonic development, according to a new study by researchers at the Stanford University School of Medicine. The researchers also found that elder...
Patients with Sickle Cell Disease Living Longer
https://reachmd.com/news/patients-sickle-cell-disease-living-longer/1633199/
Photo: E. Jason Wambsgans/Chicago Tribune PhillyVoice.com Treatment for sickle cell disease has come a long way since the 1970s when the life expectancy of people living with it was less than 20 years. People with sickle cell disease are not only living longer – life expectancy is now 42 to 47 y...
Misconceptions of Embryonic Stem Cell Potential
https://reachmd.com/programs/clinicians-roundtable/misconceptions-of-embryonic-stem-cell-potential/965/
In this segment, Dr. James Sherley explains relationship between stem cells and human organs. He proposes that the future of embryonic stem cells are mis-represented and will not ever be able to deliver upon the many promises made.
Making Progress With Stem Cell Treatments
https://reachmd.com/programs/clinicians-roundtable/making-progress-with-stem-cell-treatments/2489/
A journal Nature report that scientists cloned an embryo of a monkey and harvested its stem cells have grabbed headlines, but just how much progress are we really making in stem cell treatments? Dr. Douglas Losordo, head of the program in Cardiovascular Medicine at Northwestern University tells the